Skip to main content
SpringerLink
Log in

Immunotherapeutic Prospects of Infectious Diseases

  • Conference proceedings
  • © 1990

Overview

Editors:
  1. K. Noel Masihi

    1. Robert-Koch-Institut, Bundesgesundheitsamtes, Berlin 65, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Werner Lange

    1. Robert-Koch-Institut, Bundesgesundheitsamtes, Berlin 65, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (54 papers)

  1. Front Matter

    Pages I-XVIII
    Download chapter PDF

  2. Immunomodulators in Infectious Diseases

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. Immunopharmacology of a Class of Synthetics with Therapeutic Potential in Infections and Other Types of Diseases

      • D. Trizio, A. M. Isetta, G. F. Doria, M. C. Fornasiero, M. Ferrari, R. Ferreccio et al.
      Pages 3-8

    3. Lentinan and its Related Polysaccharides as Host Defence Potentiators: Their Application to Infectious Diseases and Cancer

      • Goro Chihara
      Pages 9-18

    4. Purification and Endotoxin-Like Bioactivities of a Novel Amphiphile from Mycobacterium bovis BCG

      • S. Kotani, A. Nagao, T. Tamura, H. Okamura, A. Nagata, K. Aoyama et al.
      Pages 19-36

    5. Bacterial Surface Components as Immunomodulators

      • W. G. Bessler, B. Kleine, L. Biesert, S. Schlecht, R. Schaude, K-H. Wiesmüller et al.
      Pages 37-48

    6. Effect of Free and Liposome-Encapsulated MTP-PE on Klebsiella pneumoniae Infection in Mice

      • Pernella M. B. Melissen, W. v. Vianen, Y. Rijsbergen, I. A. J. M. Bakker-Woudenberg
      Pages 49-53

    7. Immunomodulatory Capacity of Drugs Evaluated in a Mouse Model of Klebsiella pneumoniae Infection

      • J. FranÄ›k, J. Malina
      Pages 55-58

    8. Modulation of Host Resistance by Polymeric Substances from Baptisia tinctoria and Echinacea purpurea

      • N. Beuscher, K.-H. Scheit, C. Bodinet, D. Egert
      Pages 59-63

    9. Antivirals in Treatment of Experimental Bacterial and Fungal Infections

      • V. B. Dimov, N. D. Ivanovska
      Pages 65-69

    10. Influence of Nonspecific Immunomodulation with Thymic Preparations on the Result of Infection in some Experimental Parasitoses

      • J. HeÅ™mánek, B. Koudela
      Pages 71-75

    11. In Vitro Influence of Bovine and Human Diacetyl-Splenopentin on Human Peripheral Blood Lymphocytes in Comparison to Thymopentin

      • H.-U. Simon, I.-J. Körner, W.-D. Döcke, K. Forner, H.-D. Volk
      Pages 77-81

    12. Some Novel Pharmacological Properties of Lentinan

      • K. MaÅ¡ek, H. Mostecká, J. Seifert, H. Farghali, G. Chihara, Y. Kaneko
      Pages 83-87

  3. AIDS

    1. Front Matter

      Pages 89-89
      Download chapter PDF

    2. Status and Current Prospects for the Immunotherapy of Human Immunodeficiency Virus (HIV) Infection

      • John W. Hadden
      Pages 91-107

    3. Biological Actions of Polysaccharides and Those Derivatives Against Cancer and AIDS

      • Y. Kaneko, Y. Yamamoto, T. Uryu
      Pages 109-119

    4. Experience with IMREG-1, a Leukocyte Derived Immunomodulator on Candidiasis and Progression of Disease in Patients with AIDS-Related Complex

      • A. Arthur Gottlieb, Marise S. Gottlieb
      Pages 121-128

    5. Reduced Replication of Human Immunodeficiency Virus in Promonocytic Cells by Bacterial Immunomodulators and Anti-Retroviral Drugs at an Early Stage of HIV-Infection

      • Beate Rohde-Schulz, K. N. Masihi, W. Lange
      Pages 129-133

    6. Abrogation of Azidothymidine-Induced Bone Marrow Toxicity by Free and Liposomal Muramyl Dipeptide

      • N. C. Phillips, C. Tsoukas, L. Chedid
      Pages 135-139

    7. Effectiveness of Diethyldithiocarbamate (DTC, Imuthiol) in Reducing the Incidence of Opportunistic Infections in Patients with AIDS and ARC. A Randomized Placebo Controlled Multicenter Study

      • E. M. Hersh, J. Caraux, L. Hessel, US Imuthiol AIDS Group
      Pages 141-142
Back to top

Keywords

About this book

The prevention and control of infectious diseases represents, even today, an important public health problem for responsible national and international authorities. Newly emerging p.athogens such as human immunodeficiency virus (HIV) , legionella, and bovine spongiform encephalopathy (BSE) have captured current public awareness. Despite significant success against smallpox, polio­ myelitis, mumps, and measles, the vast majority of infectious diseases are yet to be satisfactorily controlled. Limited efficacy of some vaccines, e. g., against influenza viruses, or their nonavailability have hampered an effective control of many infections. A meaningful reduction of the health risks posed by microbial pathogens is of crucial importance. Increased efforts need to be exerted in areas of active and passive immunization as well as in stimulation of enhanced nonspecific resistance .. Progress in the field of infectious diseases can be accelerated when a generation of new improved vaccines are developed. These vaccines should be capable of activat­ ing the cellular and the humoral immune responses as well as inducing persistent immunological memory. Development of novel regimens for enhancing natural resistance against infections is also progressively gaining in importance. The urgency increases as chemotherapy against viral and other infections further continues to be plagued by a carousel of a limited number of licensed drugs, problems of side effects, and development of drug resistance. It is becoming expedient that future strategies embrace a policy directed towards triggering mechanisms capable of inducing specific and nonspecific host defences.

Editors and Affiliations

  • Robert-Koch-Institut, Bundesgesundheitsamtes, Berlin 65, Germany

    K. Noel Masihi, Werner Lange

Bibliographic Information

  • Book Title: Immunotherapeutic Prospects of Infectious Diseases

  • Editors: K. Noel Masihi, Werner Lange

  • DOI: https://doi.org/10.1007/978-3-642-76120-1

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin, Heidelberg 1990

  • Softcover ISBN: 978-3-642-76122-5Published: 14 December 2011

  • eBook ISBN: 978-3-642-76120-1Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: XVIII, 401

  • Topics: Internal Medicine, Allergology, Immunology

Publish with us

Policies and ethics

Back to top

Search

Navigation